LinkedIn Twitter Facebook Share this page RSS

Tom Sterchi Recognized as "Life Sciences Star" by LMG Life Sciences

LMG Life Sciences has recognized Baker Sterchi Member Thomas Sterchi as a 2021 ”Life Sciences Star-Product Liability (Non IP Litigation and Enforcement)."

A guide to the leading U.S. attorneys and firms in the life sciences industry, LMG Life Sciences recognizes attorneys and firms in four categories: Regulatory, Intellectual Property, Finance & Transactional and Non-IP Litigation & Enforcement.

The selection process for the award is based on extensive research, including interviews with lawyers and clients active in the life sciences field. Life Sciences Stars are attorneys consistently recommended in the research process as reputable and effective attorneys in the industry.

Sterchi is an experienced trial lawyer who has successfully defended manufacturers of a variety of products, including pharmaceuticals and medical devices, in a number of state and federal courts.  He currently serves as national trial counsel for a prominent contrast media company. He also served as lead trial counsel in high-profile cases involving hormone therapy,  toxic shock syndrome, antibiotics and breast implants.

He has extensive experience in mass torts, multi-district litigation and in defending class action lawsuits, and has been successful in defeating class action attempts against the manufacturers of pharmaceutical and medical device products.

Sterchi has been recognized as a Life Sciences Star by the publication each year since its inception and has been recognized as a top lawyer by many other international, national and local publications, including Benchmark Litigation, Best Lawyers® in America, Kansas City Business Journal Best of the Bar, Martindale-Hubbell, Missouri & Kansas Super Lawyers, Who’s Who Legal: Life Sciences, and Who’s Who of Product Liability Defense Lawyers.

Services: Pharmaceutical & Medical Device, Product Liability
Attorneys: Thomas N. Sterchi


For Important Legal Updates and Resources on the Coronavirus Click Here.